Culture Biosciences Appoints Darcy Birse as Chief Commercial Officer
13 sept. 2023 06h53 HE
|
Culture Biosciences
South San Francisco, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences, a leading provider of innovative, future-forward bioprocessing solutions, is pleased to announce the appointment of Darcy...
SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect
11 sept. 2023 09h45 HE
|
SOHM, Inc.
CHINO HILLS, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs...
RS BioTherapeutics and National Institutes of Health Execute Research Collaboration Agreement to Evaluate Prevention and Treatment of Idiopathic Pulmonary Fibrosis
29 août 2023 11h30 HE
|
RS BioTherapeutics
CUMBERLAND, Md., Aug. 29, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, a life sciences company developing life-changing medicines for the millions of people suffering from diseases characterized by...
SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor
24 août 2023 06h30 HE
|
SOHM, Inc.
CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs...
Voyce From One Health Group Wins “Overall Healthcare Product Of The Year” In 2023 Pet Innovation Awards
17 août 2023 08h00 HE
|
Pet Innovation Awards
LOS ANGELES, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The Pet Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly...
ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023
10 août 2023 08h00 HE
|
ProPhase Labs, Inc.
Company believes that the combined value of its five operating units exceeds its current market capitalization and that each unit has significant growth potential. Company highlights...
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites
28 juil. 2023 08h00 HE
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa” or the “Company”), a clinical stage biopharmaceutical company...
[Latest] Global Mitral Valve Disease Market Size/Share Worth USD 6.1 Billion by 2032 at a 8.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
25 juil. 2023 14h20 HE
|
Custom Market Insights
Austin, TX, USA, July 25, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Mitral Valve Disease Market Size, Trends and Insights By Treatment Type (Mitral...
Biodexa Regain Compliance with NASDAQ Minimum Bid Price Requirement
24 juil. 2023 07h30 HE
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Regain Compliance with NASDAQ Minimum Bid Price Requirement Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage...
Biotech and Biopharma Executive Eliana Clark Joins Culture Biosciences’ Advisory Board
19 juil. 2023 06h39 HE
|
Culture Biosciences
SAN FRANCISCO, July 19, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences is excited to welcome Eliana Clark, PhD, Executive Vice President and Chief Technical Officer at Intellia Therapeutics, Inc., to...